Low-Dose Pioglitazone in Patients With NASH (AIM 2)

Abroad (travel likely)RecruitingPHASE2

Conditions

Type 2 Diabetes Mellitus (T2DM) · Nonalcoholic Steatohepatitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Florida, Gainesville, Florida, United States
Contact: Study coordinator (Kenneth Cusi, M.D.) · kcusi@ufl.edu · 352-294-8672
Contact: Study coordinator (Eddison Godinez Leiva, M.D.) · Eddison.GodinezLeiva@medicine.ufl.edu · 3522738519
Contact: Principal Investigator (Kenneth Cusi, MD)

Study leads

Kenneth Cusi, MD
Principal Investigator
University of Florida

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus · T2DM

Abroad (travel likely)RecruitingPHASE2

Mesa, United States · Orlando, United States

Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes

Type 2 Diabetes Mellitus (T2DM) · Food Effect · Safety and Tolerability

Abroad (travel likely)RecruitingPHASE2

Bayswater, Australia

A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Type 2 Diabetes

Abroad (travel likely)RecruitingPHASE3

Beijing, China

hUC-MSC-Exosomes for T2DM - Safety & Efficacy

Type 2 Diabetes Mellitus (T2DM)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China